Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

44 trials with published results (21%)

Research Maturity

137 completed trials (66% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

2.9%

6 terminated out of 207 trials

Success Rate

95.8%

+9.3% vs benchmark

Late-Stage Pipeline

34%

70 trials in Phase 3/4

Results Transparency

32%

44 of 137 completed with results

Key Signals

44 with results96% success

Data Visualizations

Phase Distribution

144Total
Not Applicable (60)
P 1 (1)
P 2 (13)
P 3 (13)
P 4 (57)

Trial Status

Completed137
Unknown23
Recruiting20
Not Yet Recruiting11
Terminated6
Withdrawn6

Trial Success Rate

95.8%

Benchmark: 86.5%

Based on 137 completed trials

Clinical Trials (207)

Showing 20 of 20 trials
NCT07627750Not ApplicableNot Yet Recruiting

Low-Dose Rocuronium Maintenance During Spine Surgery With Intraoperative Neurophysiological Monitoring

NCT05993390Not ApplicableRecruitingPrimary

Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients

NCT07404579Phase 2CompletedPrimary

Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults

NCT07580144Recruiting

Effect of Sarcopenia and Frailty on Rocuronium Pharmacodynamics in Geriatric Patients

NCT04911088CompletedPrimary

Electromyographic Calibration Guided by Depth of Anesthesia

NCT05471882Active Not Recruiting

Predicting Neuromuscular Recovery in Surgical Patients Using Machine Learning

NCT06945341Suspended

International Focus Group Discussion on Neuromuscular Monitoring.

NCT07003061Completed

Sarcopenia and Neuromuscular Block in Gastrointestinal Cancer Surgery

NCT07446309Phase 2RecruitingPrimary

Safety and Efficacy of HRS-9190 Compared to Cisatracurium for Continuous Intravenous Infusion in Adults

NCT03201744Not ApplicableWithdrawn

Prospective Randomized Trial of Moderate vs Deep Neuromuscular Blockade During Laparoscopic Ventral Hernia Repair

NCT05788718Completed

An Observational Study to Analyze the Prescription Pattern of Sugammadex and Its Effectiveness and Safety

NCT07478120CompletedPrimary

Muscle and Fat Mass in Preoperative Computed Tomography and a Neuromuscular Blocking Agent Dose

NCT07435792Not ApplicableNot Yet Recruiting

TetraGraph to Evaluate Onset and Recovery Times of Rocuronium

NCT07203287Phase 4Recruiting

Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease

NCT04195178CompletedPrimary

Understanding the Cognition and Decision Making of Community Anesthesiologists

NCT06220136RecruitingPrimary

Comparison of the Performances of the cTOFR and the mTOFR During Reversal of Deep Neuromuscular Blockade With Sugammadex

NCT06553131RecruitingPrimary

Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison

NCT07252921Phase 2CompletedPrimary

Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation in Adults

NCT06948409Active Not Recruiting

NMBA Reversal and Postoperative Urinary Retention

NCT06467448Completed

Comparing Train-of-Four Recovery in the Adductor Pollicis Versus the Adductor Digiti Minimi in Elective Surgery Patients

Scroll to load more

Research Network

Activity Timeline